The Trout Group

 Headquarters in New York and offices in Boston, San Francisco, London, Shanghai and
Sydney
 More than 70 clients from around the world in the life sciences and energy technology
sectors
 Key Clients: Achillion Pharmaceuticals, Inc., Boehringer Ingelheim, Columbia
Laboratories, Inc., MEI Pharma, Inc.
 Available to clients on a 24/7 basis
 Active investor relations program including:
o Institutional investors well matched to our clients’ industry segment, size and
stage of development
o Sell-side analysts who cover companies
o Investment bankers who can work with our clients towards varyious financial
goals
o High-volume brokers who trade in these sectors and can potentially add volume
and stability to a stock
 Chief Executive Officer: Jonathan B. Fassberg, MBA from Stern School of Business
 Services include:
o Development and implementation of IR strategy
o Buy-side fund targeting and sell-side analyst targeting and outreach
o Full non-deal roadshow planning, execution and feedback
o Market intelligence
o IR event planning and execution
o IR materials development
o Corporate communications support
o Communications and contingency planning around major news/events
o Advisory services through Trout Capital LLC, member FINRA/SIPC
 New Business Inquiries: bd@troutgroup.com
MacDougall Biomedical Communications, Inc.

 Headquarters in Wellesley, Massachusetts and office in Burlingame, California

 Public relations, investor relations, branding, and graphics capabilities
 Strong media and investor relationships, unmatched industry network, experienced
senior-level knowledge of the industry and positive reputation
 Honesty and integrity, passion for the life sciences field, creativity, innovation, and
results-driven approach
 Integrated Corporate Communications is their specialty and they use the full range of
tools below to implement tailored strategic solutions to help our clients achieve their
objectives:
o Investor Relations
o Public Relations
o Crisis Communications
o Scientific and Medical Communications
o Corporate Branding and Positioning
o Business Development Marketing
o Creative and Digital Services
o Conference Development and Planning
 Key Clients: Akebia Therapeutics, Allegro Diagnostics, Astra Zeneca, Novadigm
Therapeutics, Threshold Pharmaceuticals
 President: Douglas MacDougall, involved in the biotechnology industry for over 25 years
and has provided strategic communications counsel and developed corporate
communications plans for over 300 clients in the life sciences space. Member of the MIT
Venture Mentoring Service for 10 years and is on the Board of Overseers of the Boston
Museum of Science
 Contact: http://www.macbiocom.com/help/contact-us.asp
ICR Corporate Communications

 Recognized leader in financial communications

 Consistently rank as one of the top independent financial communications firms in
North America
 Currently the eighth largest independent communications firm overall as per PR Week
 Provides clients the counsel and advice they expect and need every day to manage their
most precious asset—the value of their company
 Founded in 1998 by former sell side analysts Tom Ryan, Chad Jacobs, and attorney John
Flanagan
 Staffed primarily with former senior-level Wall Street professionals and agency veterans
who not only provide advice and counsel, but also execute the work
 Industries covered: Consumer, Business Services, Private Equity, Financial Services &
Technology, Education, Energy, Insurance, Technology Internet & Telecom, Natural Resources &
Mining, Cleantech, Healthy Living, Real Estate & Property, Health Care, Industrials
 Chief Executive Officer: Thomas M. Ryan, has analyzed companies from the perspective of
corporate communications consultant, investment banker, and Wall Street Journal ranked sell-
side analyst. Currently focused on shareholder activism & short seller defense, IPOs and
secondary offerings, crises communications, M&A and executive transitions. Tom served as a
Managing Director in the equity research department of BT Alex. Brown (Deutsche Bank) and
he has participated either as an investment banker, a sell-side analyst, or communications
professional, in billions of dollars worth of investment banking transactions.

 Practices:

o Investor Relations
o Corporate Communications
o Special Situations
o Crisis Communications
o Digital Communications
 Contact: http://icrinc.com/en/contact.php